Product/Primary Packaging White Papers & Case Studies

1. Improving Uptime In Aseptic Processing Of Pharmaceutical Liquids 10/17/2018

   Maximized uptime, minimized changeover time, and efficient OEE are key factors that have influenced the acceptance of aseptic blow-fill-seal in the packaging of pharmaceutical liquids.

2. Aseptic Blow/Fill/Seal Technology vs. Traditional Aseptic Processing 10/17/2018

   Learn why blow-fill-seal technology has been gaining increasing worldwide acceptance in the parenteral drug marketplace, replacing traditional glass vial processing in a growing number of applications.

3. Aseptic Blow-Fill-Seal: A Sustainable Process For Packaging Pharma Liquids 10/17/2018

   Aseptic blow-fill-seal systems for packaging pharmaceutical liquids incorporate materials and processes that provide critical advantages for sustainable initiatives.

4. Scalable Strategies For Parenteral Dosage Form Selection 12/29/2017

   Understand the strategies which can be employed at the different stages of development when choosing parenteral dosage forms.

    

5. Ensuring Pharmaceutical Film Strength To Avoid Damaged Product 6/22/2017

   This method can be used to identify potential points of weakness in a film or seal during the manufacturing process by simulating circumstances whereby the material may burst during packaging and transport.

6. Evaluating Inhaler Performance To Ensure Clinical Efficacy 6/22/2017

   MDIs are designed to deliver precise/accurate and reproducible doses of the drug to the lungs or nose. Good performance is crucial as patients rely on their inhaler to deliver the required dose of medication at often crucial times.

7. Measuring The Hardness Of Blister Packs To Determine Effectiveness 6/22/2017

   The degree of stiffness of a blister pack will affect its effectiveness. Measuring the required force to push-through a blister pack is therefore necessary.

8. Blow-Fill-Seal For Biologics: Breaking Through In Pharma Packaging 5/3/2017

   As the industry continues its move toward biologics, innovative solutions and technologies will be needed to ensure a safe and reliable approach to the manufacturing and delivery of these drugs.

9. Gain Greater Flexibility In Pharma Packaging 1/9/2017

   In numerous pharma compa­nies, the following problem is being posed: shrinking lot sizes are constantly worsening the ratio of packaging system set-up time to running time. By Dr. Ralph Blum, Mediseal GmbH, Schloss Holte

10. Late Stage Customization For Small Lots Of Blister Packaging 12/16/2016

    Two years ago, Elaiapharm undertook the packaging of an important new solid dose product (Cipralex, an antidepressant) to be launched across a large number of international markets. The product itself is an ODT – orally dispersible tablet – formulation packed in child resistant cold form blisters.